novartis

Welcome to the 'novartis' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'novartis'.

Latest blogosphere posts tagged “novartis”

• $443 million for Vertex, $25.5M for Forma, $8M for Contour Semiconductor, & More Boston-Area Deals News

  
  Xconomy — Authority: 670
  Roundup , deals , VC Rebecca Zacks wrote: The dollar amounts ranged from the modest (FitnessKeeper) to the mammoth (Vertex) for New England tech and life sciences deals this week. —Boston’s FitnessKeeper, maker of the RunKeeper iPhone application, raised $400,000 from Cambridge, MA-based ...
  9 hours ago

• Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 670
  Roundup , Life Sciences , Alliances Rebecca Zacks wrote: Somewhere between the turkey prep and the post-pie catatonia, folks at New England’s life sciences companies managed to make some news. —Idera Pharmaceuticals (NASDAQ: IDRA ), a developer of DNA- and RNA-based drugs, announced that Swiss drug ...
  2 days ago

• Quick Take: Novartis Vaccine Chief Andrin Oswald on Swine Flu and Vaccine Business

  
  Xconomy — Authority: 670
  Life Sciences , vaccines , H1N1 Swine Flu Ryan McBride wrote: It’s been a year since Andrin Oswald took over as CEO of Novartis Vaccines and Diagnostics, the 5th-largest vaccine business in the world, headquartered right here in Cambridge, MA. I met up with Oswald before he gave a keynote speech at a ...
  2 days ago

• FDA Fast-Track Approves Novartis Seasonal Flu Vaccine

  
  MyTownTalks — Authority: 508
  David Goodhue - AHN Reporter Washington, DC (AHN) - The Food and Drug Administration fast-track approved a seasonal influenza vaccine for people 18 and older. The drug, Agriflu, is made by Novartis and Diagnostics of Siena, Italy. It is designed to combat flu viruses subtypes A and B, according to an FDA statement
  2 days ago

• MENINCOCOCCO C: LA VACCINAZIONE ABBATTE I CASI DI MALATTIA

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 152
  Dai 350 casi di meningite del 2006 ai 108 casi del 2008: questo è il risultato ottenuto grazie alla raccomandazione della vaccinazione contro il meningococco C inserita nel calendario delle vaccinazioni dell’infanzia nel 2005. Lo dimostrano i dati SIMI-ISS commentati nell’incontro di aggiornamento scientifico  ...
  2 days ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 587
  Hello, everyone. The forecast suggests a chilly day here on the Pharmalot corporate campus, but it is December, after all, so who can be surprised? Of course, this calls for a warm cup of stimulation or two, so while we prepare those and some short people for the ride to the schoolhouse, here are a few items to warm ...
  3 days ago

• Forma Therapeutics Snags $25.5M Venture Round, Punctuating Startup’s Breakout Year

  
  Xconomy — Authority: 670
  Biotech , VC , deals Luke Timmerman wrote: Anybody drawing up a list of New England’s biotech companies that really broke through in 2009 would have to consider Forma Therapeutics . The Cambridge, MA-based startup has nailed down a $25.5 million Series B venture round, which means it has now raised a ...
  3 days ago

• Impactiviti Daily 120109

  
  Impactiviti blog — Authority: 114
  Welcome back from Thanksgiving holiday! Can’t believe it’s already December… This will be the only Impactiviti Daily this week, as I am heading down to South Carolina for the graduation of my #2 son (David) from Marine boot camp. TODAY’S NEWS Layoffs. Sanofi reps are apparently getting the news ...
  3 days ago

• (INCY) Incyte Corporation Enters Into License Agreement With Novartis

  
  Stock Blog Hub — Authority: 460
  Incyte Corporation ( INCY ) entered into a collaboration and license agreement with Novartis AG ( NVS ) regarding two of its pipeline candidates – INCB18424, an oral JAK1/JAK2 inhibitor and INCB28060, an oral cMET inhibitor. While the former is currently being studied in a phase III clinical trial for ...
  3 days ago

• Glaxo Sales Reps Are Denied Overtime By Court

  
  Pharmalot — Authority: 587
  In yet another twist in the ongoing battle over whether sales reps should be paid overtime, a federal court in Arizona recently ruled that two Glaxo reps are not exempt from the overtime provisions of the Fair Labor Standards Act and, therefore, should not be paid overtime. The decision contradicts a US Labor ...
  4 days ago

• Kritische Analyse zur Schweinegrippe und deren Impfung und Rundbriefen im Internet

  
  ramgad.com — Authority: 129
  Nachdem ich immer häufiger in sozialen Netzwerken (wie z.B. Facebook.com ) Fragen in meiner alten Funktion als Mediziner (ich praktiziere nicht) gestellt bekomme, möchte ich mal versuchen der allgemeinen Panikmache im Deutschen Sprachraum entgegenzuwirken und möglichst objektiv Fakten zusammenzutragen – mit dem ...
  5 days ago

• Preemption Is Alive And Well In Michigan

  
  Pharmalot — Authority: 587
  Three Michigan women blame a pair of Novartis drugs - Aredia and Zometa - for causing their osteonecrosis, which is the death of jaw-bone tissue. But a federal appeals court has ruled they can’t proceed with their lawsuits because Michigan law bars most product liability claims, Mealey’s Emerging Drugs & ...
  1 week ago

• Novartis Parts Ways with Idera Pharma

  
  Xconomy — Authority: 670
  Life Sciences , deals , Asthma Ryan McBride wrote: Idera Pharmaceuticals said this morning that it’s losing one of its three key Big Pharma partners. Swiss drug giant Novartis has told Cambridge, MA-based Idera (NASDAQ: IDRA ) that it will terminate their four-year-old collaboration to develop drugs ...
  1 week ago

• Stocks in the news: AIG, Deere & Co., Tiffany, J. Crew, Microsoft

  
  DailyFinance — Authority: 791
  Filed under: Company News , Investing , Microsoft , Boeing , American International Group, INC. , Starbucks , Tiffany & Co. , Toyota , J. Crew , Novartis American International Group Inc. ( AIG ) has been authorized by its board to pay CEO Robert Benmosches $7 million in compensation, after it laid to ...
  1 week ago

• The Dean’s Swine Flu Frenzy Could Sweep the Nation

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  The Dean has been teaching the CollegeStock Community about his upcoming Swine Flu Stock Pick and The Dean thinks things are definitely heating up.A recent report claimed that federal health officials are concerned that traveling, family get-togethers and holiday shopping could increase the prevalence of swine flu ...
  1 week ago

• Pharmalot… Pharmalittle… Pass The Turkey

  
  Pharmalot — Authority: 587
  ‘Tis the middle of the week, but this is a short one in the US due to the Thanksgiving holiday. What will you be doing? At our place, Mrs. Pharmalot has graciously volunteered to cook a few birds (we opted for duck and cornish hen this year) and we are celebrating the long weekend with two more installments of our ...
  1 week ago

• Novartis AG (NYSE:NVS) – The ADR achieved our target price on 24 November 2009.

  
  ResearchOracle.com — Authority: 158
  In our 2Q 09 update report, dated 29 July 2009, we reiterated the Novartis AG (Novartis) ADR a BUY with a target price of US$54.78, representing an upside of 24%. The ADR achieved our target price on 24 November 2009, closing at US$55.30. Although the current market price no longer supports a BUY rating, we reiterate ...
  1 week ago

• How good a speaker is Ram Charan?

  
  Public Speaking Advice and Commentary — Authority: 122
  Ram Charan once was the best-kept secret in the business world.   Only the CEOs of companies like GE,Verizon, Novartis, Dupont, Honeywell, KLM, and Bank of America had heard ofhim.   Today, thanks to hisspeaking, his books, and his articles in BusinessWeek , HarvardBusiness Review , and Fortune , which ...
  1 week ago

• Barron’s picks 10 stocks as good dividend bets

  
  Forex and Stock Market information, MMO, SEO and IT guide — Authority: 132
  Barron’s highlighted ten companies that it sees as good bets for investments with big dividends that look safe for the long term, including Banco Santander (SAN.MC) at the top of its list and Verizon Communications (VZ.N). Barron’s Nov 23 edition cited Banco Santander’s relative financial strength in a troubled ...
  1 week ago

• The Dean’s Swine Flu Profit Storm is on Its Way

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  The Dean believes Swine Flu Frenzy will carry well into flu season and, with companies like Novartis (NYSE: NVS), GlaxoSmithKline (NYSE: GSK), Sanofi-Pasteur (NYSE: SNY) and BioCryst Pharmaceuticals (NASDAQ: BCRX) contracted to produce millions of vaccine doses, there’s billions in profits to be made.The Dean thinks ...
  1 week ago

Comments about novartis